YDES – yd bio limited - ordinary shares (US:NASDAQ)
Stock Stats
News
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA-Methylation Blood Test for Post-Treatment Breast Cancer Monitoring
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities 
Form 424B3 YD Bio Ltd
Form 6-K YD Bio Ltd For: Nov 17
Form F-1/A YD Bio Ltd
Form 6-K YD Bio Ltd For: Jun 30
Form 6-K YD Bio Ltd For: Sep 26
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.